Lupus

Browse all topics A-Z Browse all research areas A-Z

Showing 1-2 of 2

Retired Program: Accelerating Medicines Partnership® Program for Type 2 Diabetes (AMP T2D) - NIDDK

Home
About NIDDK
Research Areas
Diabetes
Accelerating Medicines Partnership® Program for Type 2 Diabetes (AMP T2D)

Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD)

Accelerating Alzheimer's Research and Drug Development

The Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD) is a precompetitive partnership among government, industry, and nonprofit organizations to transform the current model for developing new diagnostics and treatments for Alzheimer's disease.

Accelerating Medicines Partnership (AMP)

Scientific Contacts for AMP AD

Laurie Ryan, Ph.D.
Email Laurie Ryan